Delivery Order SPE2DB22D3016-SPE2DB24FAVX0
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $15,946.65 firm fixed-price contract is for the supply of 5mL vials of 1% Isosulfan Blue, a dye used in medical procedures. The contract has an ultimate completion date of August 26, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued up to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,356.52, is for the delivery of ISOSULFAN BLUE 1% VIAL 5ML, a medical supply product. The contract has a firm fixed price and an ultimate completion date of August 15, 2024. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a...
- This federal contract award is for the delivery of ISOSULFAN BLUE 1% VIAL 5ML to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The $23,290.55 firm fixed-price Delivery Order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 29, 2024, with a completion date of July 30, 2024. This contract is not set aside for any specific business type. The award is a part of Amerisourcebergen's larger Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,072.90 firm fixed-price contract is for the supply of APLISOL 5T UNIT/0.1 ML VIAL 5ML medical supplies, with a period of performance through March 25, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order under the DLA's Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,140.36, is for the delivery of a variety of pharmaceutical products and medical supplies to support military healthcare programs. The contract has a firm fixed price pricing type and a period of performance ending on April 1, 2025. This contract is part of a larger...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm-fixed price and is valued at $23,590.02, with a period of performance through February 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $18,722.57 and a period of performance through February 4, 2025. It is not designated as a set-aside contract. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which serves as a primary...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,056.24, is for the delivery of various pharmaceutical products and medical supplies to support military healthcare programs. The contract is a firm fixed-price arrangement and has an ultimate completion date of January 21, 2025. This delivery order is part of a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,030.84 contract has a performance period ending on May 28, 2024. The order is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FAVX0Delivery Order
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Isosulfan Blue 1% Vial, 5 mL. The contract has a firm fixed price of $21,632.21 and a period of performance through May 17, 2024. Amerisourcebergen is the prime contractor, and the contract was not set aside for any specific business type. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.6k | 5/16/24 |